Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, January 9, 2018

Public edition |

Newswise Cancer Research Wire for 09-Jan-2018

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Deep Sea Creatures Provide a Guiding Light in the Quest to Develop Cancer-Fighting Therapies

Scientists at the Keck School of Medicine of USC use enzymes responsible for marine animal bioluminescence to help researchers test whether cancer immunotherapies work.

– Keck Medicine of USC

Scientific Reports

Embargo expired on 09-Jan-2018 at 05:00 ET

Cancer Targeted with Reusable ‘Stinging Nettle’ Treatment

Cancer cells can be destroyed more effectively and selectively with a unique new reusable treatment, activated with a substance found in stinging nettles and ants - thanks to new research by the University of Warwick.

– University of Warwick

Nature Chemistry

Global BioLife, a Biomedical Subsidiary of Singapore eDevelopment Limited, Completes Cancer Research for New Universal Therapeutic Drug Platform

Global BioLife Inc. ("Global BioLife"), a subsidiary of Singapore Exchange-listed Singapore eDevelopment Limited ("SeD"), announced today the completion of the initial cancer research portion for the study of its new universal therapeutic drug platfo...

– Global BioLife

Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice

The most commonly used gene expression profile test, Oncotype DX®, used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers.

– Georgetown Lombardi Comprehensive Cancer Center

Journal of Clinical Oncology

Embargo expired on 08-Jan-2018 at 16:00 ET

Researchers Discover That a “Muscle” Cancer Is Not Really a Muscle Cancer

St. Jude Children’s Research Hospital oncologists have discovered the cell type that gives rise to rhabdomyosarcoma, the most prevalent soft tissue cancer in children. Previously, scientists thought the cancer arose from immature muscle cells, beca...

– St. Jude Children's Research Hospital

Cancer Cell, January 2017

Embargo expired on 08-Jan-2018 at 12:00 ET

‘Immunomap’ Suggests More is Better When it Comes to Immune Cell Receptors and Patients’ Response to Immunotherapy

Johns Hopkins scientists have used a form of artificial intelligence to create a map that compares types of cellular receptors, the chemical “antennas” on the surface of immune system T-cells. Their experiments with lab-grown mouse and human T-ce...

– Johns Hopkins Medicine

Cancer Immunology Research; R01-AI44129, CA108835ANDU01-AI113315

Beta Blockers May Boost Immunotherapy, Help Melanoma Patients Live Longer

A common, inexpensive drug that is used to prevent heart attacks and lower blood pressure may also help melanoma patients live longer.

– Penn State Health Milton S. Hershey Medical Center

Researchers Develop World's Smallest Wearable Device

A Northwestern University professor, working in conjunction with the global beauty company L’Oréal, has developed the smallest wearable device in the world. The wafer-thin, feather-light sensor can fit on a fingernail and precisely measures a pers...

– Northwestern University

In Scientific First, Researchers Grow Hairy Skin In A Dish

Researchers at Indiana University School of Medicine have successfully developed a method to grow hairy skin from mouse pluripotent stem cells—a discovery that could lead to new approaches to model disease and new therapies for the treatment of ski...

– Indiana University

Cell Reports, Jan-2018

New Cancer Model Shows Genomic Link Between Early-Stage and Invasive Breast Cancer Types

A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center.

– University of Texas M. D. Anderson Cancer Center


Embargo expired on 04-Jan-2018 at 12:00 ET

Small-Cell Lung Cancer Patients Face Barriers to Receiving Standard-of-Care Treatment

Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients do not receive these treatm...

– University of Texas M. D. Anderson Cancer Center

JAMA Oncology

Embargo expired on 04-Jan-2018 at 11:00 ET

Mechanism for Resistance to Immunotherapy Treatment Discovered

Two research groups from Dana-Farber Cancer Institute have independently discovered a genetic mechanism in cancer cells that influences whether they resist or respond to immunotherapy drugs known as checkpoint inhibitors. The scientists say the findi...

– Dana-Farber Cancer Institute


Embargo expired on 04-Jan-2018 at 14:00 ET

Specific Microbes in Digestive Tract Can Boost Success for Cancer Immunotherapy

Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma. Patients with a higher ratio of “beneficial” bacteria to “non-beneficial” bacteria all showed a clinical ...

– University of Chicago Medical Center

Science, Jan. 5, 2018

Embargo expired on 04-Jan-2018 at 14:00 ET

Lymphedema after Cancer Treatment – Special Issue of Rehabilitation Oncology Presents Research Update

Individuals who have been treated for cancer are at risk for a complication called lymphedema: swelling in the body region where lymph nodes were removed, causing pain and limited function. New research and insights on the management of cancer-relate...

– Wolters Kluwer Health: Lippincott Williams and Wilkins

Rehabilitation Oncology

Christiana Care to Offer No Cost Tumor Profiling and DNA Sequencing to Patients with Advanced or Rare Cancers

Christiana Care Health System is joining the Strata Precision Oncology Network to offer next-generation tumor profiling at no cost to patients with advanced or rare cancers. Based on the results, eligible patients will be matched to the best availabl...

– Christiana Care Health System

In New Year, Resolve to Learn Your Risks of Cancer, Diabetes, Other Diseases

Your Disease Risk measures an individual's risk of 12 common cancers and five major chronic diseases. The tool, developed by researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, inc...

– Washington University in St. Louis

New Research Sheds Light on Kinesin Motility

Similar to roadways across the country, every cell in our body has a network of paths, and a professor at Texas A&M University has zoomed in to the molecular level to research the proteins that travel along this transportation system.

– Texas A&M University

eLife, November 2017; R01GM087677; R01GM116961

Overtreatment of Low-Risk Thyroid Cancer, What Doctors and Patients Should Know about the Risks Presented by Megan R. Haymart, MD

At the American Thyroid Association Annual Meeting, Dr. Haymart discussed the controversies in the treatment of low-risk differentiated thyroid cancer and the implications for clinicians and patients alike.

– Newswise

State-of-the-Art MRI Technology Bypasses Need for Biopsy

The most common type of tumor found in the kidney is generally quite small (less than 1.5 in). These tumors are usually found by accident when CAT scans are performed for other reasons and the serendipitous finding poses a problem for doctors.

– UT Southwestern Medical Center

Journal of Urology


Researchers Seek Blood Test for Early Lung Cancer Detection

Researchers at Rush University Medical Center are trying to answer that question by working to develop a blood test for early detection of lung cancer. The National Cancer Institute awarded this endeavor a two-year $275,000 grant on Jan. 1.

– Rush University Medical Center


New Oncology Leader Named at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have named Andrew M. Evens, DO, MSc, FACP as a new oncology leader responsible for the delivery of integrated cancer care across both entities in servicing the region. Dr. Evens, whose cli...

– Rutgers Cancer Institute of New Jersey

Cancer Research Institute and Canadian Cancer Trials Group Announce Strategic Collaboration

Two leading non-profits combine efforts to accelerate cancer immunotherapy clinical trials for patients globally

– Cancer Research Institute

January Is Thyroid Awareness Month

Mount Sinai Doctors Stress Importance of Early Detection and Announce Expansion of Thyroid Services in NYC

– Mount Sinai Health System

John Grisham and Focused Ultrasound Foundation to Talk about Game-changing Technology at CES in Las Vegas

The Focused Ultrasound Foundation will join life-changing technology innovators from around the world at CES 2018, taking place January 9–12 in Las Vegas. Known as the “Global Stage for Innovation,” CES will feature more than 3,900 exhibitors t...

– Focused Ultrasound Foundation

Bluefield Innovations Pursues Broadly Applicable Cancer Target

Bluefield Innovations, a collaboration between The Johns Hopkins University and Deerfield Management to catalyze early stage therapeutic development, announced today the acceptance and funding of its first project. The target, the enzyme RNA polymera...

– Johns Hopkins Medicine





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 University of Texas M. D. Anderson Cancer Center

 UT Southwestern Medical Center


 Wolters Kluwer Health: Lippincott Williams and Wilkins

 Washington University in St. Louis

 Penn State Health Milton S. Hershey Medical Center

 Northwestern University

 University of Warwick

 Focused Ultrasound Foundation

Subscribe / Unsubscribe
Edit my preferences

© 2018 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us